Evidence map›Paper›PMID 38226652›Full record

ArticleJournal of the American Geriatrics Society2024

Real-world use of a medication out-of-pocket cost estimator in primary care one year after Medicare regulation.

Caroline E Sloan, Sarah Morton-Oswald, Valerie A Smith, Anna D Sinaiko, C Barrett Bowling, Jaejin An, Matthew L Maciejewski

Abstract readLetter
In one paragraph

Article in Journal of the American Geriatrics Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Caroline E SloanDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Sarah Morton-OswaldDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Valerie A SmithDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Anna D SinaikoHarvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
C Barrett BowlingDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Jaejin AnKaiser Permanente Southern California, Pasadena, California, USA.
Matthew L MaciejewskiDepartment of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.

Funding

Preparing For What Is Next With Aducanumab In Real World SettingsR33AG057806 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Christopher Barrett Bowling, Ana Roman Quinones · 2018 to 2026
$9.0M
Evaluating an Intervention to Improve Medication Access and Quality of Care for Underserved Populations With Chronic ConditionsR01MD017747 · NIMHD · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI SINAIKO, ANNA D · 2022 to 2025
$2.5M
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency toolsK23AG076889 · NIA · DUKE UNIVERSITY · PI Caroline Ellen Sloan · 2023 to 2026
$717k
NIA NIH HHS K23 AG076889NIA NIH HHS K23AG076889NIA NIH HHS R33 AG057806NIA NIH HHS R33AG057806NIMHD NIH HHS R01 MD017747VA RCS 10-391
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MedicarePrimary Health CareAgedDrug CostsFemaleHealth ExpendituresHumansMaleUnited States

Identifiers

PMID38226652
PMCPMC11090750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.